
About Acuradyne
Acuradyne is a Healthcare company based in Mumbai (India) founded in 2017 by Pradip Gatkine and Santosh Noronha. AI-based devices for cardiovascular disease diagnosis are developed. Acuradyne has raised $124.36 thousand across 3 funding rounds from investors including Saince and SINE. Acuradyne was last valued at $917.49 thousand in December 2021. Acuradyne offers products and services including Smart Diagnostic Tools and Early Stage Detection Tools. Its focus areas include HealthTech, Healthcare IT, Value Based Care and Care Coordination. Its legal entity in India is Acuradyne Medical Systems Private Limited (U74999MH2017PTC292485).
Company details
Acuradyne was founded in 2017 in Mumbai, India, and operates in the healthcare sector with a focus on IoT-connected systems. Software and devices for AI-based diagnosis of cardiovascular diseases have been created by the company. Operations center on integrating technology for medical applications, supported by co-founders Pradip Gatkine and Santosh Noronha. The domain acuradyne.com serves as the primary online presence.
- Headquarters Mumbai, India
- Founders Pradip Gatkine, Santosh Noronha
- SectorsHealthcare
- Website acuradyne.com
- Social LinkedIn X Facebook
- Legal Name Acuradyne Medical Systems Private Limited
- Date of Incorporation 16 Mar, 2017
- Jurisdiction Mumbai, Maharashtra, India
- Net Loss-₹38.5 Lakh
FY 2023 · 0% margin
- EBITDA-₹18.5 Lakh
FY 2023 · 0% margin
- Total Equity Funding$124.36K (USD)
in 3 rounds
- Latest Funding Round$79.67K (USD), Seed
Dec 2021
- InvestorsSaince
& 1 more
Associated legal entities of Acuradyne
Acuradyne operates through Acuradyne Medical Systems Private Limited (active). Its filings, financials, charges and directors are on the company page.
| Legal entity | Status | Incorporated | Registered in | Revenue (FY 2023) | Employees | Directors | Company page |
|---|---|---|---|---|---|---|---|
| Acuradyne Medical Systems Private Limited CIN U74999MH2017PTC292485 | Active | 16 Mar 2017 | Mumbai, Maharashtra | 5 | View details |
Products & Services of Acuradyne
Acuradyne offers a comprehensive portfolio of products and services, including Smart Diagnostic Tools and Early Stage Detection Tools.
AI-powered tools for early detection of heart disease and health insights.
Devices enabling clinicians to prevent disease onset through precise monitoring.
Funding Insights of Acuradyne
Acuradyne has successfully raised a total of $124.36K across 3 strategic funding rounds. The most recent funding activity was a Seed round of $79.67 thousand completed in December 2021. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $124,356
- Total Rounds 3
- Last Round Seed β $79,666
- First Round $30,642
(Mar 2018)
- Investors Count 2
All 3 funding rounds of Acuradyne with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
Last known valuation $917,488 (Dec 2021). 2 investors in total: 2 institutional.
Investors in Acuradyne
Acuradyne has secured backing from 2 investors, including institutional and venture fund investors. Prominent investors backing the company include Saince and SINE.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Sector-agnostic startups are accelerated by SINE, backed by IIT Bombay. | sineiitb.org | Mumbai, India | ||
Saince delivers clinical documentation tools and services for healthcare organizations. | 2002 | saince.com | Alpharetta, United States |
Investor details for Acuradyne
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Board of directors of Acuradyne Medical Systems Private Limited (Acuradyne)
Acuradyne Medical Systems Private Limited is the primary company behind Acuradyne. The board of Acuradyne Medical Systems Private Limited currently have 5 directors; the longest-serving is Sushanth Dayanand Poojary, appointed in 2017. 1 earlier director has ceased.
| Director | Designation | Appointed | Tenure | Entity |
|---|---|---|---|---|
| Sushanth Dayanand Poojary DIN 07232531 | Director | 16 Mar 2017 | 9 yrs 7 mo | Acuradyne Medical Systems Private Limited |
| Meha Harsh Mani Vyas DIN 07765951 | Director | 16 Mar 2017 | 9 yrs 7 mo | Acuradyne Medical Systems Private Limited |
| Santosh Bonaventure Noronha DIN 07953846 | Director | 29 Dec 2017 | 8 yrs 10 mo | Acuradyne Medical Systems Private Limited |
| Pradip Rupkumar Gatkine DIN 09166992 | Director | 17 May 2021 | 5 yrs 5 mo | Acuradyne Medical Systems Private Limited |
| Vedantham Raghuvir DIN 02884898 | Director | 31 Mar 2022 | 4 yrs 6 mo | Acuradyne Medical Systems Private Limited |
People of Acuradyne
2 people are tracked at Acuradyne (2 in leadership).
| Name | Role | Group |
|---|---|---|
| Co-Founder | Leadership | |
| Co-Founder | Leadership |
Complete people profiles for Acuradyne
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Financials of Acuradyne
Figures of Acuradyne Medical Systems Private Limited, the primary company behind Acuradyne, for FY 2023. Net loss was -₹38.5 Lakh (0% margin). EBITDA was -₹18.5 Lakh (0% margin). Revenue has grown at a compounded annual rate of -100% over three years and -100% over five years.
- -₹38.5 LakhNet loss · 0% margin
- -₹18.5 LakhEBITDA · 0% margin
- ₹1.6 LakhPaid-up capital
- -100%Revenue CAGR, 3 years
- -100%Revenue CAGR, 5 years
Balance sheet, profit and loss, cash flow and ratios of Acuradyne Medical Systems Private Limited are on its company page.
Detailed financial statements for Acuradyne
Statement rows, ratios, five-year trends and downloadable financials of the group companies require an active premium plan.
- Statement rows
- Financial ratios
- Five-year trends
- Downloads
Verified entity values are shown only after access is granted.
Timeline of Acuradyne
3 dated milestones of Acuradyne across 4 years, from founding to its latest funding, stage changes and deals.
- Founded Acuradyne is founded.
- Funding First funding round of $31K.
- Funding Latest funding round, Seed, of $80K.
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track β from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Acuradyne
Acuradyne was founded in 2017 and raised its 1st funding round 1 year after it was founded.
Acuradyne is headquartered in Mumbai, India. It is registered at Mumbai, Maharashtra, India.
Acuradyne is a funded company, having raised a total of $124.36K across 3 funding rounds to date. The company's 1st funding round was a Seed of $30.64K, raised on Mar 2018.
Acuradyne was founded in 2017 in Mumbai, India, and operates in the healthcare sector with a focus on IoT-connected systems. Software and devices for AI-based diagnosis of cardiovascular diseases have been created by the company. Operations center on integrating technology for medical applications, supported by co-founders Pradip Gatkine and Santosh Noronha. The domain acuradyne.com serves as the primary online presence.
Acuradyne offers Smart Diagnostic Tools and Early Stage Detection Tools.
The valuation of Acuradyne is $917.49K as of Dec 2021.
Acuradyne operates through Acuradyne Medical Systems Private Limited.
The legal entities of Acuradyne currently have 5 directors, including Pradip Rupkumar Gatkine, Sushanth Dayanand Poojary, Vedantham Raghuvir and others.